✦ LIBER ✦
A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-α antibody afelimomab in patients with sepsis syndrome
✍ Scribed by James Gallagher; Charles Fisher; Bruce Sherman; Mark Munger; Bruce Meyers; Travis Ellison; Steven Fischkoff; William T. Barchuk; Leah Teoh; Raja Velagapudi
- Book ID
- 105838610
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 133 KB
- Volume
- 27
- Category
- Article
- ISSN
- 1432-1238
No coin nor oath required. For personal study only.